Bio-Techne Corporation logo
TECHBio-Techne Corporation

Is the P/E ratio high or low?

The P/E ratio of 102.90 is 38% above its 5-year average of 74.35, around the middle of its 5-year range (30.02–154.62).

As of Saturday, June 27, 2026. 2.21% below its 12-month average of 105.23.

PE Ratio (102.90) = Close Price ($71.00) / Diluted TTM EPS ($0.69)

PEG Ratio|P/B Ratio|EPS|All Metrics
TECH PE Ratio

TECH PE Ratio Chart

102.90
+59.81% 1Y
TECH PE Ratio

TECH Average PE Ratio Chart

TECH PE Ratio

TECH Current vs Average PE Ratio Chart

TECH PE Ratio Metrics

PE RATIO

102.90

PE RATIO AVG TTM

105.23

PE RATIO AVG 3Y

68.43

PE RATIO AVG 5Y

74.35

PE RATIO AVG 10Y

63.52

PE RATIO AVG 15Y

50.72

PE RATIO AVG 20Y

43.27

CURRENT VS TTM AVG

-2.21%

CURRENT VS 3Y AVG

+50.37%

CURRENT VS 5Y AVG

+38.39%

CURRENT VS 10Y AVG

+62.00%

CURRENT VS 15Y AVG

+102.88%

CURRENT VS 20Y AVG

+137.80%

TECH Competitors' PE Ratio

NAMEMARKET CAPPE RATIOTTM3Y5Y
Bio-Techne Corporation (TECH)$11.12B102.90105.2368.4374.35
Insulet Corp. (PODD)vs ›$10.86B35.7772.422272.873788.27
Baxter International Inc. (BAX)vs ›$11.38BN/A44.5334.4137.43
Molina Healthcare, Inc. (MOH)vs ›$11.79B64.3019.3418.6321.11
Walgreens Boots Alliance, Inc. (WBA)vs ›$10.37BN/A33.4814.6325.08
Charles River Laboratories International, Inc. (CRL)vs ›$10.20BN/A225.6691.3972.20
Tempus AI, Inc. (TEM)vs ›$9.80BN/AN/AN/AN/A
Henry Schein, Inc. (HSIC)vs ›$9.68B25.6622.9123.6021.61
Revvity, Inc. (RVTY)vs ›$12.61B53.8244.2241.2633.91
Align Technology, Inc. (ALGN)vs ›$12.78B29.4829.1442.2347.17

P/E vs. its own history

At 102.9, P/E is richer than usual, sitting higher than 95% of its 20-year history.

20-year low

16.1

median

37.4

20-year high

154.6

cheaperricher

P/E Comparison

Trailing P/E

102.9

Forward P/E

34.4

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$71.00

÷

Forward EPS (Est.)

$2.06

=

Forward P/E

34.43

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PE Ratio FAQ

What is the P/E ratio for Bio-Techne Corporation (TECH)?
The P/E ratio for TECH stock is 102.90.
Is Bio-Techne Corporation's P/E ratio high or low?
The P/E ratio of 102.90 is 38% above its 5-year average of 74.35, around the middle of its 5-year range (30.02–154.62).
What is the TTM average P/E ratio for Bio-Techne Corporation (TECH)?
The TTM average P/E ratio for TECH stock is 105.23.
What is the 3Y average P/E ratio for Bio-Techne Corporation (TECH)?
The 3Y average P/E ratio for TECH stock is 68.43.
What is the 5Y average P/E ratio for Bio-Techne Corporation (TECH)?
The 5Y average P/E ratio for TECH stock is 74.35.
What is the 10Y average P/E ratio for Bio-Techne Corporation (TECH)?
The 10Y average P/E ratio for TECH stock is 63.52.
What is the 15Y average P/E ratio for Bio-Techne Corporation (TECH)?
The 15Y average P/E ratio for TECH stock is 50.72.
What is the 20Y average P/E ratio for Bio-Techne Corporation (TECH)?
The 20Y average P/E ratio for TECH stock is 43.27.

TECH PE Ratio History

DATEPE RATIO
2026-06-26102.90
2026-06-25102.46
2026-06-2485.33
2026-06-2381.54
2026-06-2280.59
2026-06-1883.97
2026-06-1779.71
2026-06-1681.20
2026-06-1581.41
2026-06-1278.26
2026-06-1178.29
2026-06-1076.09
2026-06-0978.86
2026-06-0876.30
2026-06-0575.35
2026-06-0477.07
2026-06-0373.70
2026-06-0272.13
2026-06-0173.61
2026-05-2974.90
2026-05-2873.68
2026-05-2769.70
2026-05-2669.52
2026-05-2269.87
2026-05-2168.65
2026-05-2067.68
2026-05-1965.90
2026-05-1864.39
2026-05-1562.75
2026-05-1464.84
2026-05-1365.06
2026-05-1268.72
2026-05-1168.72
2026-05-0870.09
2026-05-0773.78
2026-05-0668.71
2026-05-05111.14
2026-05-04107.33
2026-05-01107.88
2026-04-30108.47
2026-04-29101.86
2026-04-28104.92
2026-04-27108.06
2026-04-24106.25
2026-04-23102.35
2026-04-22114.86
2026-04-21117.00
2026-04-20118.78
2026-04-17116.14
2026-04-16112.47
2026-04-15114.69
2026-04-14115.02
2026-04-13112.80
2026-04-10108.90
2026-04-09108.96
2026-04-08108.25
2026-04-07105.55
2026-04-06105.49
2026-04-02104.18
2026-04-01104.86
2026-03-31102.47
2026-03-30102.04
2026-03-2799.90
2026-03-26103.33
2026-03-25103.31
2026-03-24102.80
2026-03-23101.96
2026-03-20100.94
2026-03-19101.16
2026-03-1899.63
2026-03-17100.12
2026-03-1695.71
2026-03-1399.71
2026-03-12100.92
2026-03-11105.14
2026-03-10103.57
2026-03-09107.59
2026-03-06105.67
2026-03-05109.59
2026-03-04113.43
2026-03-03111.75
2026-03-02113.37
2026-02-27115.69
2026-02-26113.57
2026-02-25113.47
2026-02-24112.94
2026-02-23107.37
2026-02-20112.78
2026-02-19114.22
2026-02-18116.33
2026-02-17114.71
2026-02-13117.51
2026-02-12116.75
2026-02-11124.41
2026-02-10127.06
2026-02-09128.39
2026-02-06130.94
2026-02-05129.14
2026-02-04134.65
2026-02-03131.90
2026-02-02133.16
2026-01-30130.80
2026-01-29130.57
2026-01-28133.80
2026-01-27139.24
2026-01-26138.02
2026-01-23139.10
2026-01-22142.14
2026-01-21145.67
2026-01-20141.98
2026-01-16140.14
2026-01-15142.78
2026-01-14139.59
2026-01-13135.43
2026-01-12135.84
2026-01-09134.08
2026-01-08131.80
2026-01-07132.76
2026-01-06133.22
2026-01-05128.63
2026-01-02121.73
2025-12-31120.02
2025-12-30120.65
2025-12-29120.90
2025-12-26120.86
2025-12-24120.80
2025-12-23120.92
2025-12-22120.33
2025-12-19118.92
2025-12-18116.53
2025-12-17116.31
2025-12-16117.22
2025-12-15119.78
2025-12-12119.41
2025-12-11122.98
2025-12-10124.14
2025-12-09120.04
2025-12-08123.04
2025-12-05125.88
2025-12-04129.67
2025-12-03130.24
2025-12-02128.47
2025-12-01130.12
2025-11-28131.65
2025-11-26131.90
2025-11-25134.39
2025-11-24129.57
2025-11-21125.57
2025-11-20119.86
2025-11-19117.98
2025-11-18118.67
2025-11-17119.61
2025-11-14121.18
2025-11-13123.98
2025-11-12125.31
2025-11-11120.78
2025-11-10117.27
2025-11-07117.16
2025-11-06118.73
2025-11-05122.33
2025-11-04132.83
2025-11-03133.17
2025-10-31136.02
2025-10-30132.52
2025-10-29134.83
2025-10-28139.00
2025-10-27139.67
2025-10-24143.28
2025-10-23143.61
2025-10-22138.67
2025-10-21137.96
2025-10-20135.96
2025-10-17134.48
2025-10-16133.91
2025-10-15129.52
2025-10-14128.85
2025-10-13129.67
2025-10-10127.52
2025-10-09130.22
2025-10-08131.65
2025-10-07128.67
2025-10-06134.61
2025-10-03136.85
2025-10-02134.98
2025-10-01130.26
2025-09-30120.93
2025-09-29113.54
2025-09-26112.72
2025-09-25109.74
2025-09-24111.35
2025-09-23115.04
2025-09-22115.30
2025-09-19115.54
2025-09-18115.20
2025-09-17112.00
2025-09-16112.57
2025-09-15112.22
2025-09-12111.43
2025-09-11115.67
2025-09-10110.78
2025-09-09117.83
2025-09-08117.63
2025-09-05118.28
2025-09-04115.04
2025-09-03115.96
2025-09-02116.13
2025-08-29118.76
2025-08-28118.11
2025-08-27122.22
2025-08-26123.46
2025-08-25123.28
2025-08-22124.11
2025-08-2165.85
2025-08-2066.26
2025-08-1966.91
2025-08-1864.99
2025-08-1565.37
2025-08-1465.54
2025-08-1366.72
2025-08-1264.43
2025-08-1161.16
2025-08-0861.49
2025-08-0761.16
2025-08-0660.82
2025-08-0566.63
2025-08-0466.93
2025-08-0166.94
2025-07-3166.74
2025-07-3070.38
2025-07-2970.57
2025-07-2871.40
2025-07-2571.68
2025-07-2471.30
2025-07-2367.45
2025-07-2264.78
2025-07-2161.30
2025-07-1863.44
2025-07-1764.99
2025-07-1663.16
2025-07-1562.71
2025-07-1464.17
2025-07-1166.02
2025-07-1066.35
2025-07-0964.13
2025-07-0864.24
2025-07-0762.85
2025-07-0364.80
2025-07-0264.85
2025-07-0163.51
2025-06-3062.74
2025-06-2763.22
2025-06-2664.39
2025-06-2563.28
2025-06-2460.98
2025-06-2360.12
2025-06-2060.84
2025-06-1861.13
2025-06-1760.37
2025-06-1662.96
2025-06-1361.61

Showing the most recent 260 of 5,032 data points. The chart above shows the full history.

Related Metrics

PEG RatioP/B RatioEPSAll Metrics
See the Lowest P/E Ratio Stocks ranking →

About Bio-Techne Corporation

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Minneapolis, MN
3,100 employees
www.bio-techne.com
Healthcare / Biotechnology
Sector
Healthcare
Industry
Biotechnology
CEO
Kim Kelderman
View full financials